Antony Mattessich compensation by year
OCULAR THERAPEUTIX Summary Compensation Table · all 8 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| Salary | $237,628 | $564,850 | $581,796 | $600,000 | $630,000 | $660,000 | $686,400 | $245,550 |
| Bonus | $596,500 | $372,801 | $325,000 | $432,000 | $410,000 | $386,100 | $459,545 | $0 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $984,173 | $684,044 | $934,472 |
| Option awards | $5,192,708 | $1,592,748 | $1,218,600 | $1,130,400 | $6,053,684 | $2,067,082 | $1,443,721 | $2,004,744 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $154,963 | $96,130 | $750 | $750 | $3,250 | $3,250 | $3,002 | $5,597,598 |
| Total | $6,181,799 | $2,625,529 | $2,126,146 | $2,163,150 | $7,096,934 | $4,100,605 | $3,276,712 | $8,782,364 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCULAR THERAPEUTIX, INC DEF 14A filed April 29, 2025, accession 0001558370-25-005868, and prior-year filings. Open the filing on EDGAR.
How this page was built: the OCULAR THERAPEUTIX, INC filed document, accession 0001558370-25-005868. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.
OCULAR THERAPEUTIX’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Pravin Dugel | Executive Chair, President and Chief Executive Officer (3) | $18,574,830 |
| Antony Mattessich · this page | Former President and Chief Executive Officer | $8,782,364 |
| Peter Kaiser | Chief Development Officer | $6,629,358 |
| Jeffrey Heier | Chief Scientific Officer | $6,599,173 |
| Donald Notman | Chief Operating Officer and Chief Financial Officer | $2,069,341 |
The full OCULAR THERAPEUTIX compensation record
free company briefThis page is one person within OCULAR THERAPEUTIX's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the OCULAR THERAPEUTIX proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OCULAR THERAPEUTIX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.